-- 
Israeli Stocks: BioCancell Therapeutics, Mazor, XTL

-- B y   R o n i t   G o o d m a n
-- 
2011-03-08T14:24:53Z

-- http://www.bloomberg.com/news/2011-03-08/israeli-stocks-biocancell-mazor-xtl-biopharmaceuticals.html
(Corrects description of Mazor in fourth paragraph.)    Israel ’s TA-25 Index fell for the
second time this week, decreasing 0.4 percent to 1,271.05 at
12:39 p.m. in  Tel Aviv .  The following stocks rose or fell today. Symbols are in
parentheses.  BioCancell Therapeutics Inc.  (BICL IT) advanced to the
highest level since March 3, gaining 5.7 percent to 2.70
shekels. The Israeli developer of cancer drugs named Ruben Krupik as chairman.    Mazor Robotics Ltd. (MZOR)   rose the most in almost a
week, increasing 1.3 percent to 9.95 shekels. The developer of
surgical robots said it sold a SpineAssist system to the
University of California, Irvine hospital. The sale is expected
to have a “positive” effect on the marketing of the product in
the U.S., the company said in a statement to the Tel Aviv Stock
Exchange today.    XTL Biopharmaceuticals Ltd. (XTLB)   jumped the most in
more than two months, advancing 17 percent to 0.48 shekel after
the Israeli biopharmaceutical company said it raised 6.5 million
shekels ($1.8 million) from the sale of shares and options. The
shares were sold at 0.485 shekel each.  To contact the reporter on this story:
Ronit Goodman in Tel Aviv at 
 rgoodman9@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  